Author:
K. Geetha Bhavani,K. Bala Murali Krishna,N. Srinivasu,D. Ramachandran,N. V.V.S.S Raman,B. Hari Babu
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference7 articles.
1. International Conference on Harmonisation Q3A-Q3D Impurities-International Council for Harmonization guidelines.
2. Regulation of genotoxic and carcinogenic impurities in drug substances and products;McGovern;Trends Anal. Chem,2006
3. A rationale for determining testing, and controlling specific impurities in pharmaceuticals that posses potential for genotoxicity;Muller;Reg. Toxicol. Pharmacol.,2006
4. Guideline on the limits of genotoxic impurities, EMA guidance EMEA/CHMP/QWP/251344/2006.
5. Guideline for Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk, M7 ICH, 2014.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献